nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.0158	0.0158	CcSEcCtD
Nitazoxanide—Leukocytosis—Methylprednisolone—ankylosing spondylitis	0.0148	0.0148	CcSEcCtD
Nitazoxanide—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.0144	0.0144	CcSEcCtD
Nitazoxanide—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.0144	0.0144	CcSEcCtD
Nitazoxanide—Leukocytosis—Betamethasone—ankylosing spondylitis	0.0135	0.0135	CcSEcCtD
Nitazoxanide—Leukocytosis—Dexamethasone—ankylosing spondylitis	0.0135	0.0135	CcSEcCtD
Nitazoxanide—Lung disorder—Methotrexate—ankylosing spondylitis	0.013	0.013	CcSEcCtD
Nitazoxanide—Amenorrhoea—Prednisone—ankylosing spondylitis	0.0125	0.0125	CcSEcCtD
Nitazoxanide—Leukocytosis—Prednisone—ankylosing spondylitis	0.0117	0.0117	CcSEcCtD
Nitazoxanide—Increased appetite—Prednisolone—ankylosing spondylitis	0.0117	0.0117	CcSEcCtD
Nitazoxanide—Increased appetite—Triamcinolone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Nitazoxanide—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.0108	0.0108	CcSEcCtD
Nitazoxanide—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00978	0.00978	CcSEcCtD
Nitazoxanide—Increased appetite—Betamethasone—ankylosing spondylitis	0.00978	0.00978	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00891	0.00891	CcSEcCtD
Nitazoxanide—Influenza—Triamcinolone—ankylosing spondylitis	0.00876	0.00876	CcSEcCtD
Nitazoxanide—Increased appetite—Prednisone—ankylosing spondylitis	0.00852	0.00852	CcSEcCtD
Nitazoxanide—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00736	0.00736	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00706	0.00706	CcSEcCtD
Nitazoxanide—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00703	0.00703	CcSEcCtD
Nitazoxanide—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00701	0.00701	CcSEcCtD
Nitazoxanide—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00696	0.00696	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00615	0.00615	CcSEcCtD
Nitazoxanide—Malaise—Prednisolone—ankylosing spondylitis	0.00598	0.00598	CcSEcCtD
Nitazoxanide—Syncope—Prednisolone—ankylosing spondylitis	0.00595	0.00595	CcSEcCtD
Nitazoxanide—Back pain—Triamcinolone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Nitazoxanide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00583	0.00583	CcSEcCtD
Nitazoxanide—Hypertension—Prednisolone—ankylosing spondylitis	0.00573	0.00573	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00566	0.00566	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Nitazoxanide—Discomfort—Prednisolone—ankylosing spondylitis	0.00558	0.00558	CcSEcCtD
Nitazoxanide—Malaise—Triamcinolone—ankylosing spondylitis	0.0055	0.0055	CcSEcCtD
Nitazoxanide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Nitazoxanide—Syncope—Triamcinolone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Nitazoxanide—Syncope—Methylprednisolone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Nitazoxanide—Oedema—Prednisolone—ankylosing spondylitis	0.00541	0.00541	CcSEcCtD
Nitazoxanide—Dysuria—Methotrexate—ankylosing spondylitis	0.00541	0.00541	CcSEcCtD
Nitazoxanide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Nitazoxanide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00535	0.00535	CcSEcCtD
Nitazoxanide—Shock—Prednisolone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Nitazoxanide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00528	0.00528	CcSEcCtD
Nitazoxanide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00527	0.00527	CcSEcCtD
Nitazoxanide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00526	0.00526	CcSEcCtD
Nitazoxanide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Nitazoxanide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Nitazoxanide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Nitazoxanide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Nitazoxanide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00508	0.00508	CcSEcCtD
Nitazoxanide—Malaise—Betamethasone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Nitazoxanide—Malaise—Dexamethasone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Nitazoxanide—Oedema—Triamcinolone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Nitazoxanide—Syncope—Betamethasone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Nitazoxanide—Syncope—Dexamethasone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Nitazoxanide—Infection—Triamcinolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Nitazoxanide—Infection—Methylprednisolone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Nitazoxanide—Shock—Triamcinolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Nitazoxanide—Insomnia—Prednisolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Nitazoxanide—Shock—Methylprednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Nitazoxanide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Nitazoxanide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Nitazoxanide—Epistaxis—Methotrexate—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Nitazoxanide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Nitazoxanide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00485	0.00485	CcSEcCtD
Nitazoxanide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Nitazoxanide—Hypertension—Betamethasone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Nitazoxanide—Myalgia—Betamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Nitazoxanide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Nitazoxanide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Nitazoxanide—Discomfort—Betamethasone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Nitazoxanide—Pain—Prednisolone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Nitazoxanide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Nitazoxanide—Oedema—Dexamethasone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Nitazoxanide—Oedema—Betamethasone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Nitazoxanide—Insomnia—Triamcinolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Nitazoxanide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Nitazoxanide—Infection—Dexamethasone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Nitazoxanide—Infection—Betamethasone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Nitazoxanide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Nitazoxanide—Anaemia—Prednisone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Nitazoxanide—Shock—Dexamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Nitazoxanide—Shock—Betamethasone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Nitazoxanide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Nitazoxanide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Nitazoxanide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Nitazoxanide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Nitazoxanide—Malaise—Prednisone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Nitazoxanide—Syncope—Prednisone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Nitazoxanide—Anorexia—Betamethasone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Nitazoxanide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Nitazoxanide—Pain—Triamcinolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Nitazoxanide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Nitazoxanide—Hypertension—Prednisone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Nitazoxanide—Chills—Methotrexate—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Nitazoxanide—Myalgia—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Nitazoxanide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Nitazoxanide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Nitazoxanide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Nitazoxanide—Insomnia—Betamethasone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Nitazoxanide—Discomfort—Prednisone—ankylosing spondylitis	0.00405	0.00405	CcSEcCtD
Nitazoxanide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Nitazoxanide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Nitazoxanide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Nitazoxanide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Nitazoxanide—Oedema—Prednisone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Nitazoxanide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Nitazoxanide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Nitazoxanide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Nitazoxanide—Infection—Prednisone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Nitazoxanide—Back pain—Methotrexate—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Nitazoxanide—Shock—Prednisone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Nitazoxanide—Pain—Dexamethasone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Nitazoxanide—Pain—Betamethasone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Nitazoxanide—Tachycardia—Prednisone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Nitazoxanide—Anorexia—Prednisone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Nitazoxanide—Anaemia—Methotrexate—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Nitazoxanide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Nitazoxanide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Nitazoxanide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Nitazoxanide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Nitazoxanide—Malaise—Methotrexate—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Nitazoxanide—Dizziness—Prednisolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Nitazoxanide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nitazoxanide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nitazoxanide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nitazoxanide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nitazoxanide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nitazoxanide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Nitazoxanide—Insomnia—Prednisone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Nitazoxanide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Nitazoxanide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Nitazoxanide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Nitazoxanide—Myalgia—Methotrexate—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Nitazoxanide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Nitazoxanide—Rash—Prednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Nitazoxanide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Nitazoxanide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Nitazoxanide—Headache—Prednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Nitazoxanide—Discomfort—Methotrexate—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Nitazoxanide—Constipation—Prednisone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Nitazoxanide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Nitazoxanide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Nitazoxanide—Infection—Methotrexate—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Nitazoxanide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Nitazoxanide—Asthenia—Betamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Nitazoxanide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Nitazoxanide—Nausea—Prednisolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Nitazoxanide—Pruritus—Betamethasone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Nitazoxanide—Pruritus—Dexamethasone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Nitazoxanide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Nitazoxanide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Nitazoxanide—Rash—Triamcinolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Nitazoxanide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Nitazoxanide—Anorexia—Methotrexate—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nitazoxanide—Rash—Methylprednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nitazoxanide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nitazoxanide—Headache—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Nitazoxanide—Headache—Methylprednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Nitazoxanide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Nitazoxanide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Nitazoxanide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Nitazoxanide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Nitazoxanide—Dizziness—Dexamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Nitazoxanide—Dizziness—Betamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Nitazoxanide—Insomnia—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Nitazoxanide—Nausea—Triamcinolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Nitazoxanide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Nitazoxanide—Somnolence—Methotrexate—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Nitazoxanide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Nitazoxanide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Nitazoxanide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Nitazoxanide—Vomiting—Betamethasone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Nitazoxanide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Nitazoxanide—Rash—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Nitazoxanide—Rash—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Nitazoxanide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Nitazoxanide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Nitazoxanide—Headache—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Nitazoxanide—Headache—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Nitazoxanide—Asthenia—Prednisone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Nitazoxanide—Pain—Methotrexate—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Nitazoxanide—Pruritus—Prednisone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nitazoxanide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Nitazoxanide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Nitazoxanide—Nausea—Betamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Nitazoxanide—Nausea—Dexamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Nitazoxanide—Dizziness—Prednisone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Nitazoxanide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Nitazoxanide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Nitazoxanide—Vomiting—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Nitazoxanide—Rash—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nitazoxanide—Dermatitis—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nitazoxanide—Headache—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Nitazoxanide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Nitazoxanide—Asthenia—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Nitazoxanide—Nausea—Prednisone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Nitazoxanide—Pruritus—Methotrexate—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Nitazoxanide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Nitazoxanide—Dizziness—Methotrexate—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Nitazoxanide—Vomiting—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Nitazoxanide—Rash—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Headache—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Nausea—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
